Pharmaceuticals

Behind every name for a business, product or prescription drug is someone writing hundreds of possible names. Lieba Golden-Koulendros has made a career out it.

The generic drug industry in the U.S. has saved people billions and billions of dollars. But it faces new economic pressure today.

Government insurer won't cover Aduhelm's $28,000-a-year price tag except for clinical trials.

The stockpile is a way to address shortages of some medicines. Some of the ingredients will be stored for emergency use.

The antibiotics sector needs a revitalizing shot. The U.S. government's response to COVID may hold some answers.

The Trump administration has given Kodak hundreds of millions of dollars to produce chemicals for COVID-19 treatments. But the venerable photography company will have to compete with a global supply chain.

What does it mean for the rest of the world if countries have dibs on vaccine doses?

China plays a big part in the supply chain of Americans' generic drugs

Some experts doubt that the rule would have been capable of lowering drug prices.

Industry analysts expect the price for the single-treatment therapy to be anywhere from $1.5 million to $5 million.